Literature DB >> 11861234

Inhaler devices for asthma: do we follow the guidelines?

F Child1, S Davies, S Clayton, A A Fryer, W Lenney.   

Abstract

BACKGROUND: Despite national guidelines for asthma treatment, many children have troublesome symptoms. AIM: To assess the extent to which the use of inappropriate inhaler devices contributes to this problem.
METHODS: Of 14 813 questionnaires distributed to schoolchildren, 6996 (47%) were returned identifying 1444 children using asthma inhalers. Inhalers were categorised as age appropriate or inappropriate according to national guidelines and were compared with those used by 75 patients attending a hospital clinic.
RESULTS: A total of 35% of "schools" and 4% of "clinic" children reported using an inappropriate inhaler device. Most were using metered dose inhalers alone. Twenty four per cent of "schools" children < or = 5 years old did not use a spacer. Both children and parents overestimated the child's ability to use their inhaler.
CONCLUSIONS: Large numbers of children are given inhalers they cannot use. To improve asthma care we must ensure that prescriptions reflect the age and ability of the child. Recent recommendations by the Department of Health in England and Wales stress the importance of seamless care between primary and secondary services. As the management of childhood asthma is guided primarily by secondary care providers, it is therefore imperative that general paediatricians know the difficulties and issues which are occurring in the community. This will enable them to lead and support necessary change.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861234      PMCID: PMC1719133          DOI: 10.1136/adc.86.3.176

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

Review 1.  Asthma control: where do we fail?

Authors:  J C Kips; R A Pauwels
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

Review 2.  Issues at the interface between primary and secondary care in the management of common respiratory disease. 3: Providing better asthma care: what is there left to do?

Authors:  R G Neville; B G Higgins
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Mechanism of osteoporosis in patients with cystic fibrosis.

Authors:  S Teramoto
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

4.  Asthma drug delivery devices for children.

Authors:  C O'Callaghan; P W Barry
Journal:  BMJ       Date:  2000-03-11

Review 5.  Delivery systems: the science.

Authors:  C O'Callaghan
Journal:  Pediatr Pulmonol Suppl       Date:  1997-09

Review 6.  The burden of pediatric asthma.

Authors:  W Lenney
Journal:  Pediatr Pulmonol Suppl       Date:  1997-09

7.  Peak inspiratory flow through Turbuhaler in acute asthma.

Authors:  P H Brown; A C Ning; A P Greening; A McLean; G K Crompton
Journal:  Eur Respir J       Date:  1995-11       Impact factor: 16.671

8.  Spacer devices in the treatment of asthma.

Authors:  C O'Callaghan; P Barry
Journal:  BMJ       Date:  1997-04-12

9.  Successful implementation of spacer treatment guideline for acute asthma.

Authors:  C V Powell; G R Maskell; M K Marks; M South; C F Robertson
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

10.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

Authors:  K F Rabe; P A Vermeire; J B Soriano; W C Maier
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

View more
  3 in total

1.  The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.

Authors:  Tjalling W de Vries; Hilde Tobi; Eric Schirm; Paul van den Berg; Eric J Duiverman; Lolkje T W de Jong-van den Berg
Journal:  Eur J Clin Pharmacol       Date:  2005-12-20       Impact factor: 2.953

Review 2.  Closer to an 'ideal inhaler' with the Easyhaler: an innovative dry powder inhaler.

Authors:  Henry Chrystyn
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 3.  [Wheezing in infants and toddlers: new insights].

Authors:  Elisabeth Horak
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.